🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Assessment of Invasive Genetic Testing in Fetuses With Isolated Intrauterine Growth Restriction Diagnosed After 28 Weeks of Gestation at Strasbourg University Hospitals (2016-2023)

Recruitingn/aAges 18 Years - anyFemaleUniversity Hospital, Strasbourg, France
NCT07864272 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study evaluates the diagnostic yield of invasive genetic testing in fetuses with isolated intrauterine growth restriction diagnosed after 28 weeks of gestation, in order to better define indications for invasive procedures and improve clinical counseling.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Maternal age ≥ 18 years * Referral after 28 weeks of gestation for estimated fetal weight \< 3rd percentile, isolated condition * Management at Strasbourg University Hospitals between 01/01/2016 and 01/01/2023 * No documented opposition to reuse of medical data for research Exclusion Criteria: * Suspected fetal structural anomaly or infectious cause * Multiple pregnancy * Incomplete genetic workup
💊

What it tests

  • Not listed
📍

Where

1 site
Service de Gynécologie et Obstétrique - CHU de Strasbourg - France
Strasbourg, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy